Reply to J.-S. Ryu et al and A.T. Berman et al
- 20 May 2014
- journal article
- other
- Published by American Society of Clinical Oncology (ASCO) in Journal of Clinical Oncology
- Vol. 32 (15) , 1632-1633
Abstract
No abstract availableThis publication has 7 references indexed in Scilit:
- Predicting Survival in Non–Small-Cell Lung Cancer Using Positron Emission Tomography: Several Conclusions From Multiple ComparisonsJournal of Clinical Oncology, 2014
- Prognostic Impact of [18F]Fluorodeoxyglucose Positron Emission Tomography Scanning in the Era of Molecular OncologyJournal of Clinical Oncology, 2014
- Prediction of Survival by [18F]Fluorodeoxyglucose Positron Emission Tomography in Patients With Locally Advanced Non–Small-Cell Lung Cancer Undergoing Definitive Chemoradiation Therapy: Results of the ACRIN 6668/RTOG 0235 TrialJournal of Clinical Oncology, 2013
- Surrogate endpoints for overall survival in chemotherapy and radiotherapy trials in operable and locally advanced lung cancer: a re-analysis of meta-analyses of individual patients' dataThe Lancet Oncology, 2013
- Noise Considerations for PET Quantification Using Maximum and Peak Standardized Uptake ValueJournal of Nuclear Medicine, 2012
- Defining Local-Regional Control and Its Importance in Locally Advanced Non-small Cell Lung CarcinomaJournal of Thoracic Oncology, 2012
- From RECIST to PERCIST: Evolving Considerations for PET Response Criteria in Solid TumorsJournal of Nuclear Medicine, 2009